Neuronetics, Inc.

Perceptive Amendment

As previously disclosed, on July 25, 2024, the Company entered into the Perceptive Facility.

On March 12, 2026, the Company entered into the Perceptive Fifth Amendment. The Perceptive Fifth Amendment amends the Perceptive Facility to (i) modify certain financial covenants and waive certain financial reporting requirements and (ii) make an optional prepayment of the outstanding principal amount of the loans in an amount equal to $5,000,000.

The foregoing summary of the Perceptive Fifth Amendment does not purport to be complete and is qualified in its entirety by reference to the Perceptive Fifth Amendment, a copy of which is filed as Exhibit 10.7 hereto and incorporated herein by reference.

Daniel L. Reuvers Employment Agreement and Severance Agreement

As previously disclosed, on March 12, 2026, the Board appointed Daniel L. Reuvers as the Company’s President and Chief Executive Officer effective on the date that Mr. Reuvers commences employment with the Company, which is expected to be March 23, 2026 (the “Reuvers Start Date”).

The Company has entered into an employment agreement with Mr. Reuvers that becomes effective on the Reuvers Start Date (the “Employment Agreement”). Under the terms of the Employment Agreement, Mr. Reuvers will: (A) receive an initial annual base salary of $730,000; (B) be eligible for a discretionary annual cash bonus targeted at 100% of his then-current base salary; and (C) receive a grant of 1,500,000 restricted stock units, with 500,000 of such units vesting in substantially equal installments on the first, second, and third anniversary of the Reuvers Start Date, in all cases subject to Mr. Reuvers’s continued employment with the Company on each such vesting date.

In the event of termination by the Company without cause or by Mr. Reuvers for good reason, Mr. Reuvers will be entitled to severance benefits, including 12 months of base salary, a prorated target bonus, and continued health coverage pursuant to that certain Severance Agreement effective as of the Reuvers Start Date (the “Severance Agreement”).

The foregoing summaries of the Employment Agreement and the Severance Agreement are not complete and are qualified in their entirety by reference to the full text of the Employment Agreement and the Severance Agreement, as applicable, copies of which are filed as Exhibit 10.58 and Exhibit 10.59, respectively, to this Annual Report on Form 10-K and are incorporated herein by reference.

Mr. Reuvers has also entered into the Company’s executive indemnification agreement, executive restrictive covenant and severance agreement, and restrictive covenant and invention assignment agreement, and confidential information and invention assignment agreement substantially in the forms of the Company’s form of agreements.